Cigna Group $CI Holdings Raised by ProShare Advisors LLC

ProShare Advisors LLC increased its position in Cigna Group (NYSE:CI) by 12.6% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 48,913 shares of the health services provider’s stock after purchasing an additional 5,489 shares during the period. ProShare Advisors LLC’s holdings in Cigna Group were worth $16,170,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Summit X LLC increased its holdings in Cigna Group by 77.5% in the second quarter. Summit X LLC now owns 3,791 shares of the health services provider’s stock worth $1,253,000 after buying an additional 1,655 shares during the last quarter. Midwest Trust Co acquired a new stake in Cigna Group in the 2nd quarter valued at approximately $581,000. Acadian Asset Management LLC increased its position in Cigna Group by 252.7% during the second quarter. Acadian Asset Management LLC now owns 29,181 shares of the health services provider’s stock worth $9,640,000 after acquiring an additional 20,907 shares during the period. Global Wealth Management Investment Advisory Inc. increased its holdings in shares of Cigna Group by 3.5% during the 2nd quarter. Global Wealth Management Investment Advisory Inc. now owns 8,536 shares of the health services provider’s stock worth $2,822,000 after purchasing an additional 289 shares during the period. Finally, CSM Advisors LLC bought a new stake in shares of Cigna Group in the second quarter valued at about $14,628,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Trading Up 3.7%

Shares of CI opened at $267.82 on Wednesday. The stock has a fifty day moving average price of $291.71 and a two-hundred day moving average price of $302.28. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00. The company has a market cap of $71.54 billion, a price-to-earnings ratio of 14.62, a PEG ratio of 0.88 and a beta of 0.44.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. The company had revenue of $69.57 billion during the quarter, compared to analyst estimates of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same period last year, the company posted $7.51 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be given a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Thursday, December 4th. Cigna Group’s dividend payout ratio is presently 26.64%.

Insider Transactions at Cigna Group

In other news, CEO David Cordani acquired 4,134 shares of Cigna Group stock in a transaction on Monday, November 3rd. The shares were purchased at an average price of $241.88 per share, with a total value of $999,931.92. Following the acquisition, the chief executive officer owned 157,935 shares in the company, valued at $38,201,317.80. This represents a 2.69% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Nicole S. Jones sold 28,526 shares of the stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the transaction, the insider owned 25,648 shares in the company, valued at $7,694,400. The trade was a 52.66% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.70% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on CI shares. Raymond James Financial restated a “strong-buy” rating on shares of Cigna Group in a research report on Monday, November 3rd. Leerink Partners decreased their price target on shares of Cigna Group from $300.00 to $270.00 in a research note on Friday, October 31st. Cowen restated a “buy” rating on shares of Cigna Group in a research note on Tuesday, November 4th. Truist Financial reduced their price objective on shares of Cigna Group from $375.00 to $310.00 in a report on Friday, October 31st. Finally, Robert W. Baird set a $372.00 target price on shares of Cigna Group in a research report on Thursday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $339.73.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.